Thus, the upregulation in the expression of Group II mGluRs would lead to decrease of the release of glutamate neurotransmitter, and then weaken synaptic transmission between glutamatergic neurons in the APP/PS1 AD mice. Here, APP is linked to Alzheimer disease.